Concepedia

Pretreatment CA 19-9 Level as a Prognostic Factor in Patients with Advanced Pancreatic Cancer Treated with Gemcitabine

Everardo D. Saad, Marcel Cerqueira César Machado, Dalia Wajsbrot, Roberto Abramoff, Paulo M. Hoff, Jacques Tabacof, Artur Katz, Sérgio D. Simon, Rene Claúdio Gansl

International Journal of Gastrointestinal Cancer · 2002 · 111 citations · 32 references

DOI

Concepts

References

32

Global cancer statistics

Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text

, , +15

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al. · Journal of Clinical Oncology · 1997 · 5.9K citations

, , +16

Cancer statistics, 2000

Robert T. Greenlee, Thomas S. Murray, S. Bolden et al. · CA A Cancer Journal for Clinicians · 2000 · 3.9K citations · Full text

, , +16

Phase II study of gemcitabine in patients with advanced pancreatic cancer

J Carmichael, U. Fink, RC Russell et al. · British Journal of Cancer · 1996 · 370 citations · Full text

, , +11

Change in serum prostate-specific antigen as a marker of response to cytotoxic therapy for hormone-refractory prostate cancer.

David C. Smith, Roberta Dunn, Myla Strawderman et al. · Journal of Clinical Oncology · 1998 · 215 citations

, , +17